96675 ⎘
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
COMPOUNDS FOR DELIVERING GLUTATHIONE TO A TARGET AND METHODS OF MAKING AND USING THE SAME
#2MICROORGANISM WITH HIGH TRIPEPTIDE PRODUCTIVITY AND USE THEREOF
#3METHODS AND REAGENTS FOR ANALYZING PROTEIN-PROTEIN INTERFACES
#4PSMA Imaging Agents
#5PSMA Imaging Agents
#6LIPOPEPTIDES, NANOPARTICLES AND METHODS OF USE
#7NOVEL COMPOUNDS AND ANTIBACTERIAL COMPOSITION COMPRISING THE SAME
#8COMPOUND FOR ALCOHOLIC LIVER INJURY, PREPARATION METHOD, COMPOSITION, FOOD AND USE
#9POLYPEPTIDE HAVING MMP2-INHIBITORY EFFECT
#10Antibody-Drug Conjugates Comprising an Anti-BCMA Antibody
#11MACROCYCLIC COMPOUNDS AS PROTEASOME INHIBITORS
#12RADIOMETAL-BINDING COMPOUNDS FOR DIAGNOSIS OR TREATMENT OF PROSTATE SPECIFIC MEMBRANE ANTIGEN-EXPRESSING CANCER
#13COMPOUNDS HAVING TRIPLE ACTIVITIES OF THROMBOLYSIS, ANTITHROMBOTIC AND RADICAL SCAVENGING
#14DISULFIDE BOND CONTAINING COMPOUNDS AND USES THEREOF
#151,2,4-Oxadiazole Compounds as Inhibitors of CD47 Signalling Pathways
#16Macrocyclic compounds as proteasome inhibitors
#17NRP-1 BINDING INHIBITORY PEPTIDES AND USES THEREOF
#18SALT FORMS OF S-(N, N-DIETHYLCARBAMOYL)GLUTATHIONE
#19METHODS AND REAGENTS FOR ANALYZING PROTEIN-PROTEIN INTERFACES
#20SPECIFICALLY-SHAPED CRYSTAL OF COMPOUND AND METHOD FOR PRODUCING SAME
#21COMPOUNDS HAVING TRIPLE ACTIVITIES OF THROMBOLYSIS, ANTITHROMBOTIC AND RADICAL SCAVENGING
#22SPECIFICALLY-SHAPED CRYSTAL OF COMPOUND AND METHOD FOR PRODUCING SAME
#23Therapeutic compounds and methods
#24MONOTHIOETHER CROSSLINKERS IN POLYMERS AND APPLICATIONS THEREOF
#251,2,4-oxadiazole compounds as inhibitors of CD47 signaling pathways
#26Imaging agent
#27PSMA Imaging Agents
#28PSMA imaging agents
#29PSMA imaging agents
#30CRYSTAL OF REDUCED GLUTATHIONE AND METHOD FOR PRODUCING SAME
#31NOVEL RADIOMETAL-BINDING COMPOUNDS FOR DIAGNOSIS OR TREATMENT OF PROSTATE SPECIFIC MEMBRANE ANTIGEN-EXPRESSING CANCER
#32INHIBITION OF OXIDATIVE STRESS, GLYCATION, AND PROTEIN CROSSLINKING
#33Disulfide bond containing compounds and uses thereof
#34Dual-enzyme responsive peptides
#35COMPOUNDS HAVING TRIPLE ACTIVITIES OF THROMBOLYSIS, ANTITHROMBOTIC AND RADICAL SCAVENGING
#36GLUTATHIONE-CHOLESTEROL DERIVATIVES AS BRAIN TARGETING AGENTS
#37System and method for biosynthesis
#38Methods and compositions for modulating transport of a drug
#39Dipeptide piperidine derivatives
#401,2,4-oxadiazole compounds as inhibitors of CD47 signalling
#41COMPOUNDS FOR DELIVERING GLUTATHIONE TO A TARGET AND METHODS OF MAKING AND USING THE SAME
#42Crystal of reduced glutathione and method for producing same
#43Crystal of reduced glutathione and method for producing same
#44Water-soluble rapamycin derivatives
#45Tricyclic prodrugs
#46Cyclic peptidomimetics, compositions containing them and their use in the treatment of diseases associated with angiogenesis
#47Method for manufacturing a metal nanostructure having a chiral structure comprising regioselectivity adsorbing a peptide on the surface of a metal seed particle
#48NOVEL LIGANDS FOR PREVENTION OF NEUROTOXICITY OF THE ALZHEIMER'S DISEASE RELATED AMYLOID-BETA PEPTIDE
#49Methods and reagents for analyzing protein-protein interfaces
#50PSMA imaging agents
#51Methods and reagents for analyzing protein-protein interfaces
#52Method for producing alpha-form crystal of reduced glutathione, and method for storing said crystal
#53Process for preparing compounds having triple activities of thrombolysis, antithrombosis, and radical scavenging
#54Methods and compositions for modulating transport of a drug
#55Crystal of reduced glutathione
#56Cholecystokinin 2 receptor targeted NIR imaging and use thereof
#57Methods and reagents for analyzing protein-protein interfaces
#58Tricyclic prodrugs
#59Method for producing gamma-glutamylvalylglycine or a salt thereof
#60Gamma glutamyl-valine synthase, and method for producing gamma glutamyl-valyl-glycine
#61Ligands for prevention of neurotoxicity of the alzheimer's disease related amyloid-beta peptide
#62Use of Novel Coumarins as Glutathione and Thiol Labels
#63Peptidomimetics with antiangiogenic activity
#64Mutant glutamate-cysteine ligase and method for manufacturing gamma glutamyl-valyl-glycine
#65Docosahexaenoyl ethanolamides
#66PSMA imaging agents
#67Crystalline forms of s-acetyl glutathione, their preparations and uses in pharmaceutical and nutraceutical formulations
#68PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND THE TREATMENT OF DEGENERATIVE SKIN DISORDERS ESPECIALLY CAUSED BY IONIZING RADIATIONS
#69Macrocyclic insulin-degrading enzyme (IDE) inhibitors and uses thereof
#70Compounds having triple activities of thrombolysis, antithrombosis, and radical scavenging, synthesis, and use thereof
#71Compounds useful in the treatment and/or care of the skin and their cosmetic or pharmaceutical compositions
#72Vectors for delivery of agents across biological membranes
#73Method for manufacturing reduced glutathione
#74Method for producing γ-glutamyl-valyl-glycine crystal
#75Prodrugs for selective anticancer therapy
#76Crystalline oxidized glutathione and production method therefor
#77Trapping reagents for reactive metabolites screening
#78Lysine oligomer derivative and cartilage tissue marker made thereof
#79Tyrosine based linkers for the releasable connection of peptides
#80Docosahexaenoyl ethanolamides
#81PRODRUGS OF D-GAMMA-GLUTAMYL-D-TRYPTOPHAN AND D-GAMMA-GLUTAMYL-L-TRYPTOPHAN
#82Biosynthetically generated pyrroline-carboxy-lysine and site specific protein modifications via chemical derivatization of pyrroline-carboxy-lysine and pyrrolysine residues
#83Macrocyclic insulin-degrading enzyme (IDE) inhibitors and uses thereof
#84Method for producing γ-glutamylvalylglycine or a salt thereof
#85Solid oxidized glutathione salt and method for producing same
#86Glutathione alkylester isotopologue and method for detecting reactive metabolite
#87Substituted piperazin-2,5-diones as multifunctional bioactive compounds
#88Glutathione analogs and uses thereof
#89Peptide for use in the treatment of skin conditions
#90Methods for preparing internally constrained peptides and peptidomimetics
#91Process for producing reduced glutathione
#92RGD mimetic γ-AApeptides and methods of use
#93Efficient peptide couplings and their use in the synthesis and isolation of a cyclopenta (G) quinazoline trisodium salt
#94Prolinamide derivatives as thrombin inhibitors, preparation method and application thereof
#95Pharmaceutical composition for preventing or treating Th17-mediated disease comprising poly-gamma-glutamic acid
#96Glutathione-Lanthionine Compounds and Methods Related Thereto
#97Cyclized peptidomimetic small molecule inhibitors of the WDR5 and MLL1 interaction
#98Chemical synthesis and anti-tumor and anti-metastatic effects of dual functional conjugate
#99Crystalline D-isoglutamyl-D-tryptophan and the mono ammonium salt of D-isoglutamyl-D-tryptophan
#100Crystalline D-isoglutamyl-D-tryptophan and the mono ammonium salt of D-isoglutamyl-D-tryptophan
#101Non-crystalline oxidized glutathione and production method therefor
#102Crystalline oxidized glutathione and production method therefor
#103Methods for Preparing Internally Constrained Peptides and Peptidomimetics
#104Separation of protein monomers from aggregates by solid weak anion exchange support functionalized with amine moieties
#105Lanthionine derivatives
#106Kokumi-imparting agent
#107Inhibition of sweat malodor
#108Process for and intermediates in the preparation of canfosfamide and its salts
#109CRYSTALLINE EZATIOSTAT HYDROCHLORIDE ANSOLVATE
#110Glutathione Derivatives and Their Uses for the Treatment of Viral Diseases
#111ORALLY BIOAVAILABLE D-GAMMA-GLUTAMYL-D-TRYPTOPHAN
#112Process for production of reduced glutathione
#113Cell-targeting nanoparticles and uses thereof
#114TRAPPING COMPOUNDS AND METHOD FOR IDENTIFYING REACTIVE METABOLITES
#115Tablet formulation of ezatiostat
#116Preparation of crystalline ezatiostat hydrochloride ansolvate form D
#117CRYSTALLINE EZATIOSTAT HYDROCHLORIDE ANSOLVATE
#118TABLET FORMULATION OF EZATIOSTAT
#119Biosynthetically generated pyrroline-carboxy-lysine and site specific protein modifications via chemical derivatization of pyrroline-carboxy-lysine and pyrrolysine residues
#120LIVER DISEASE MARKER, METHOD AND APPARATUS FOR MEASURING THE SAME, AND METHOD FOR ASSAYING PHARMACEUTICAL PREPARATION
#121Radical scavenger and active oxygen eliminating agent
#122Cyclopenta{G}quinazoline derivatives for the treatment of rheumatoid arthritis or acute myeloid leukaemia
#123Kokumi-imparting agent
#124PROMOTER FOR BICARBONATE SECRETION IN GASTROINTESTINAL TRACT
#125Urokinase inhibitors, production and use thereof
#126Use of novel coumarins as glutathione and thiol labels
#127Methods for improved uptake of biological molecules
#128Novel Immunoregulatory Peptides, Compositions and Uses Thereof
#129Anti-cancer cyclopenta(g)quinazoline compounds
#130Peptide derivatives and cosmetic composition comprising the same
#131Methods for preparing internally constrained peptides and peptidomimetics
#132Anti-cancer cyclopenta []quinazonline compounds
#133GUANIDINIUM DELIVERY CARRIERS
#134RADICAL SCAVENGER AND ACTIVE OXYGEN ELIMINATING AGENT
#135Kokumi-imparting agent, method of using, and compositions containing same
#136PROPHYLACTIC OR THERAPEUTIC AGENT FOR DIARRHEA
#137Crystal of glutathione and process for production thereof
#138Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture
#139Anti-cancer cyclopenta [g] quinazoline compounds
#140Substituted piperazin-2,5-diones and their use as multifunctional bioactive compounds
#141Crystalline D-isoglutamyl-D-tryptophan and the mono ammonium salt of D-isoglutamyl-D-tryptophan
#142Production and use of novel peptide-based agents with bispecific antibodies
#143Kokumi-imparting agent
#144Salt Enhancing Compounds and Use
#145Compositions and Methods for Attenuating Mitochondria-Mediated Cell Injury
#146Kokumi flavour compounds and use
#147Anti-cancer cyclopenta[g]quinazoline compounds
#148Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof
#149Thiosuccinic acid derivatives and the use thereof
#150GSH adducts and uses thereof
#151COMPOSITIONS AND METHODS TO PREVENT TOXICITY INDUCED BY NONSTEROIDAL ANTIINFLAMMATORY DRUGS
#152ENDOGENOUS THIADIAZABICYCLO GLUTATHIONE-ADDUCT
#153METHODS FOR PRODUCTION OF THE OXIDIZED GLUTATHIONE COMPOSITE WITH CIS-DIAMMINEDICHLOROPLATINUM AND PHARMACEUTICAL COMPOSITIONS BASED THEREOF REGULATING METABOLISM, PROLIFERATION, DIFFERENTIATION AND APOPTOTIC MECHANISMS FOR NORMAL AND TRANSFORMED CELLS
#154Organoselenium compound for cancer chemoprevention
#155Isotopically labeled trapping agent and method for identifying reactive metabolites
#156METHODS AND COMPOSITIONS FOR IMPROVED UPTAKE OF BIOLOGICAL MOLECULES
#157Inhibition of sweat malodor
#158Anti-cancer cyclopenta[G]quinazoline compounds
#159Glutathione Derivatives and Their Uses for the Treatment of Viral Diseases
#160Methods for preparing internally constrained peptides and peptidomimetics
#161Methods for production of the oxidized glutathione composite with CIS-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
#162Amino acid conjugates providing for sustained systemic concentrations of GABA analogues
#163Inactivators and bivalent inhibitors of glyoxalase I and methods of inhibiting tumor growth
#164Methods for production of the oxidized glutathione composite with CIS-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
#165Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof
#166Guanidinium delivery carriers
#167Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
#168Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof
#1692-Amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoic acid amide derivatives
#170Novel ampiphilic fluorocarbon molecular vectors for biomedical and medical use
#171Cell adhesion inhibitors
#172Tripeptide and tetrapeptide thioethers
#173Tripeptide and tetrapeptide sulfones
#174Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent(s)
#175Process for and intermediates in the preparation of canfosfamide and its salts
#176Compositions and methods for attenuating mitochondria-mediated cell injury
#177Modulation of interaction between Nod1 and Gram-negative bacteria by Nod1 response to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island (cagPAI)
#178Organoselenium compounds for cancer chemoprevention
#179Production and use of novel peptide-based agents with bispecific antibodies
#180Methods for preparing internally constrained peptides and peptidomimetics
#181Bacterial efflux pump inhibitors and methods of treating bacterial infections
#182Anti-inflammatory compositions and methods
#183Enone cancer therapeutics
#184Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
#185Urokinase inhibitors, production and use thereof
#186Vitronectin receptor antagonist pharmaceuticals
#187Therapeutic compositions
#188Novel compounds
#189Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
#190Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
#191Methods and compositions for modulating transport of a drug